News Wor­thy

Health & Nutrition - - HEALTH FLASH -

An anti-vi­ral pill taken daily by thou­sands of men across Syd­ney and other parts of Aus­tralia led to a glob­ally un­prece­dented re­duc­tion in new HIV cases, show­ing that a tar­geted, pre­ven­ta­tive ap­proach may ac­cel­er­ate progress on end­ing the AIDS epi­demic. New cases of HIV among gay and bi­sex­ual men fell by al­most a third to the low­est on record, ac­cord­ing to the world’s first study to mea­sure the im­pact of Gilead Sciences Inc.’s Tru­vada pill on re­duc­ing the AIDS-caus­ing virus in a large pop­u­la­tion. The re­sults, pub­lished in the ‘Lancet HIV’ med­i­cal jour­nal, may pave the way for other states and coun­tries to stop trans­mis­sion of the virus with the use of a treat­ment called pre-ex­po­sure pro­phy­laxis, or PrEP.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.